| Name | Title | Contact Details |
|---|---|---|
Omri Gottesman |
Chief Executive Officer | Profile |
Zucara Therapeutics, a CDRD and MaRS Innovation portfolio company, is developing the first drug therapy to prevent hypoglycemia in people with diabetes. Our first-in-class therapeutic is focused on improving glucagon counterregulation by inhibiting somatostatin which is dysregulated in Type 1 diabetes.
Human Genome Sciences, Inc. is a Rockville, MD-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Temporary Technical Services Inc is a Jackson, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ms Sarah's Creations Of Beauty is a Daly City, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Point Medical Corporation is a Crown Point, IN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.